Literature DB >> 26449663

Search for familial clustering of multiple myeloma with any cancer.

C Frank1, M Fallah1, T Chen1, E K Mai2, J Sundquist3,4, A Försti1,3, K Hemminki1,3.   

Abstract

Multiple myeloma (MM) is a disease of immunoglobulin-producing plasma cells, which reside mainly in the bone marrow. Family members of MM patients are at a risk of MM, but whether other malignancies are in excess in family members is not established and is the aim of this study. MM patients (24 137) were identified from the Swedish Cancer Registry from years 1958 to 2012. Relative risks (RRs) were calculated for MM defined by any cancer diagnosed in first-degree relatives and compared with individuals whose relatives had no cancer. MM was reliably associated with relative's colorectal, breast and prostate cancers, non-thyroid endocrine tumors, leukemia and cancer of unknown primary; in addition, MM was associated with subsites of bone and connective tissue tumors and of non-Hodgkin lymphoma, including lymphoplasmacytic lymphoma/Waldenström macroglobulinema (RR 3.47). MM showed a strong association (RR 1.91) in colorectal cancer families, possibly as part of an unidentified syndrome. All the associations of MM with discordant cancers are novel suggesting that MM shares genetic susceptibility with many cancers. The associations of MM bone and connective tissue tumors were supported by at least two independent results. Whether the results signal bone-related biology shared by MM and these tumors deserves further study.

Entities:  

Mesh:

Year:  2015        PMID: 26449663     DOI: 10.1038/leu.2015.279

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  25 in total

1.  Familial risks in cancer of unknown primary: tracking the primary sites.

Authors:  Kari Hemminki; Jianguang Ji; Jan Sundquist; Xiaochen Shu
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

Review 2.  Multiple myeloma.

Authors:  Antonio Palumbo; Kenneth Anderson
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

3.  Do discordant cancers share familial susceptibility?

Authors:  Kari Hemminki; Jan Sundquist; Andreas Brandt
Journal:  Eur J Cancer       Date:  2011-10-25       Impact factor: 9.162

Review 4.  Pathogenesis of myeloma.

Authors:  Kenneth C Anderson; Ruben D Carrasco
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

5.  Clustering of concordant and discordant cancer types in Swedish couples is rare.

Authors:  Marianne Weires; Justo Lorenzo Bermejo; Jan Sundquist; Kari Hemminki
Journal:  Eur J Cancer       Date:  2010-07-23       Impact factor: 9.162

Review 6.  Cancer of unknown primary site.

Authors:  Nicholas Pavlidis; George Pentheroudakis
Journal:  Lancet       Date:  2012-03-12       Impact factor: 79.321

Review 7.  The genetic architecture of multiple myeloma.

Authors:  Gareth J Morgan; Brian A Walker; Faith E Davies
Journal:  Nat Rev Cancer       Date:  2012-04-12       Impact factor: 60.716

8.  The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies.

Authors:  Kari Hemminki; Jianguang Ji; Andreas Brandt; Seyed Mohsen Mousavi; Jan Sundquist
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

9.  Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Lynn R Goldin; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

10.  Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.

Authors:  Daniel Chubb; Niels Weinhold; Peter Broderick; Bowang Chen; David C Johnson; Asta Försti; Jayaram Vijayakrishnan; Gabriele Migliorini; Sara E Dobbins; Amy Holroyd; Dirk Hose; Brian A Walker; Faith E Davies; Walter A Gregory; Graham H Jackson; Julie A Irving; Guy Pratt; Chris Fegan; James Al Fenton; Kai Neben; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Fiona M Ross; Christian Straka; Hermann Einsele; Christian Langer; Elisabeth Dörner; James M Allan; Anna Jauch; Gareth J Morgan; Kari Hemminki; Richard S Houlston; Hartmut Goldschmidt
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

View more
  14 in total

1.  Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families.

Authors:  Jazlyn Read; Judith Symmons; Jane M Palmer; Grant W Montgomery; Nicholas G Martin; Nicholas K Hayward
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

2.  Direct evidence for a polygenic etiology in familial multiple myeloma.

Authors:  Britt-Marie Halvarsson; Anna-Karin Wihlborg; Mina Ali; Konstantinos Lemonakis; Ellinor Johnsson; Abhishek Niroula; Carrie Cibulskis; Niels Weinhold; Asta Försti; Evren Alici; Christian Langer; Michael Pfreundschuh; Hartmut Goldschmidt; Ulf-Henrik Mellqvist; Ingemar Turesson; Anders Waage; Kari Hemminki; Todd Golub; Hareth Nahi; Urban Gullberg; Markus Hansson; Björn Nilsson
Journal:  Blood Adv       Date:  2017-04-07

3.  The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study.

Authors:  Gudbjörg Jonsdottir; Sigrún H Lund; Magnus Björkholm; Ingemar Turesson; Malin Hultcrantz; Anna Porwit; Yogesh S Jethava; Ola Landgren; Sigurdur Y Kristinsson
Journal:  Blood Adv       Date:  2017-11-22

4.  Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2019-08-08       Impact factor: 22.113

5.  Search for familial clustering of cancer in monoclonal gammopathy of unknown significance.

Authors:  K Hemminki; A Försti; J Sundquist; X Li
Journal:  Blood Cancer J       Date:  2016-07-08       Impact factor: 11.037

6.  The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications.

Authors:  Kari Hemminki; Asta Försti; Raimo Tuuminen; Otto Hemminki; Hartmut Goldschmidt; Kristina Sundquist; Jan Sundquist; Xinjun Li
Journal:  Sci Rep       Date:  2016-06-22       Impact factor: 4.379

7.  Risk of other Cancers in Families with Melanoma: Novel Familial Links.

Authors:  Christoph Frank; Jan Sundquist; Akseli Hemminki; Kari Hemminki
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

8.  The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression.

Authors:  Mina Ali; Ram Ajore; Anna-Karin Wihlborg; Abhishek Niroula; Bhairavi Swaminathan; Ellinor Johnsson; Owen W Stephens; Gareth Morgan; Tobias Meissner; Ingemar Turesson; Hartmut Goldschmidt; Ulf-Henrik Mellqvist; Urban Gullberg; Markus Hansson; Kari Hemminki; Hareth Nahi; Anders Waage; Niels Weinhold; Björn Nilsson
Journal:  Nat Commun       Date:  2018-04-25       Impact factor: 14.919

9.  Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study.

Authors:  Subhayan Chattopadhyay; Hauke Thomsen; Miguel Inacio da Silva Filho; Niels Weinhold; Per Hoffmann; Markus M Nöthen; Arendt Marina; Karl-Heinz Jöckel; Börge Schmidt; Sonali Pechlivanis; Christian Langer; Hartmut Goldschmidt; Kari Hemminki; Asta Försti
Journal:  Mol Med       Date:  2018-06-11       Impact factor: 6.354

10.  Multiple myeloma: family history and mortality in second primary cancers.

Authors:  Subhayan Chattopadhyay; Hongyao Yu; Amit Sud; Jan Sundquist; Asta Försti; Akseli Hemminki; Kari Hemminki
Journal:  Blood Cancer J       Date:  2018-08-07       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.